R

    ResMed Inc (RMD)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $240.13
    -0.20 (-0.08%)

    Market Cap: $34.63B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    88%(35/40)
    Avg Surprise
    +5.31%
    Streak
    12 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$2.69
    Range$2.62 - $2.78
    13 analysts
    EPS Revisions
    1
    0
    7d
    1
    2
    30d
    EPS Estimate Drift
    90d ago$2.86+6.5%
    60d ago$2.85+6.1%
    30d ago$2.83+5.3%
    7d ago$2.69+0.0%
    Current$2.69
    Revenue Consensus
    $1.4B
    Range$1.4B - $1.4B
    16 analysts
    Period ending Dec 31, 2026
    EPS Consensus$3.04
    Range$2.99 - $3.12
    13 analysts
    EPS Revisions
    1
    0
    7d
    1
    1
    30d
    EPS Estimate Drift
    90d ago$3.06+0.9%
    60d ago$3.05+0.5%
    30d ago$3.04+0.0%
    7d ago$3.04+0.0%
    Current$3.04
    Revenue Consensus
    $1.5B
    Range$1.4B - $1.5B
    16 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$3.04---
    Sep 26EST
    		-$2.69---
    Jun 26
    Reported Aug 6
    		$2.95$2.90+1.72%Beat+15.7%
    Mar 26
    Reported Apr 30
    		$2.86$2.80+2.14%Beat+20.7%
    Dec 25
    Reported Jan 29
    		$2.81$2.72+3.31%Beat+15.6%
    Sep 25
    Reported Oct 30
    		$2.55$2.50+2.00%Beat+15.9%
    Jun 25
    Reported Jul 31
    		$2.55$2.48+2.82%Beat+22.6%
    Mar 25
    Reported Apr 23
    		$2.37$2.36+0.42%Beat+11.3%
    Dec 24
    Reported Jan 30
    		$2.43$2.31+5.19%Beat+29.3%
    Sep 24
    Reported Oct 24
    		$2.20$2.04+7.84%Beat+34.1%
    Jun 24
    Reported Aug 1
    		$2.08$2.07+0.48%Beat+30.0%
    Mar 24
    Reported Apr 25
    		$2.13$1.91+11.52%Beat+26.8%
    Dec 23
    Reported Jan 24
    		$1.88$1.78+5.62%Beat+13.3%
    Sep 23
    Reported Oct 26
    		$1.64$1.61+1.86%Beat+8.6%
    Jun 23
    Reported Aug 3
    		$1.60$1.69-5.33%Miss+7.4%
    Mar 23
    Reported Apr 27
    		$1.68$1.59+5.66%Beat+27.3%
    Dec 22
    Reported Jan 26
    		$1.66$1.62+2.47%Beat+12.9%
    Sep 22
    Reported Oct 27
    		$1.51$1.60-5.63%Miss+0.0%
    Jun 22
    Reported Aug 11
    		$1.49$1.46+2.05%Beat+10.4%
    Mar 22
    Reported Apr 28
    		$1.32$1.44-8.33%Miss+1.5%
    Dec 21
    Reported Jan 27
    		$1.47$1.52-3.29%Miss+4.3%
    Sep 21
    Reported Oct 28
    		$1.51$1.35+11.85%Beat+18.9%
    Jun 21
    Reported Aug 5
    		$1.35$1.29+4.65%Beat+1.5%
    Mar 21
    Reported Apr 29
    		$1.30$1.27+2.36%Beat+0.8%
    Dec 20
    Reported Jan 28
    		$1.41$1.28+10.16%Beat+16.5%
    Sep 20
    Reported Oct 29
    		$1.27$1.03+23.30%Beat+36.6%
    Jun 20
    Reported Aug 5
    		$1.33$1.07+24.30%Beat+40.0%
    Mar 20
    Reported Apr 30
    		$1.29$1.08+19.44%Beat+44.9%
    Dec 19
    Reported Jan 30
    		$1.21$1.02+18.63%Beat+21.0%
    Sep 19
    Reported Oct 24
    		$0.93$0.87+6.90%Beat+14.8%
    Jun 19
    Reported Jul 25
    		$0.95$0.92+3.26%Beat+0.0%
    Mar 19
    Reported May 2
    		$0.89$0.85+4.71%Beat-3.3%
    Dec 18
    Reported Jan 24
    		$1.00$0.95+5.26%Beat+0.0%
    Sep 18
    Reported Oct 25
    		$0.81$0.79+2.53%Beat+22.7%
    Jun 18
    Reported Aug 2
    		$0.95$0.93+2.15%Beat+23.4%
    Mar 18
    Reported Apr 26
    		$0.92$0.86+6.98%Beat+29.6%
    Dec 17
    Reported Jan 22
    		$1.00$0.78+28.21%Beat+37.0%
    Sep 17
    Reported Oct 26
    		$0.66$0.66+0.00%Beat+6.5%
    Jun 17
    Reported Aug 1
    		$0.77$0.74+4.05%Beat-
    Mar 17
    Reported Apr 27
    		$0.71$0.70+1.43%Beat-
    Dec 16
    Reported Jan 23
    		$0.73$0.70+4.29%Beat-
    Sep 16
    Reported Oct 25
    		$0.62$0.65-4.62%Miss-

    Dividends

    Dividend Metrics

    Yield1.02%
    Annual/Share$2.46
    Payout Ratio19.80%
    Frequency4
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR+9.53%
    5Y CAGR+7.70%
    View RMD's full dividend history

    Key Metrics

    Valuation
    P/E Ratio21.50EV/EBITDA15.50x
    Price/FCF21.16xFCF Yield4.73%
    Profitability
    Profit Margin27.00%Operating Margin30.90%
    ROE24.30%ROIC20.78%
    Financial Health
    Debt/Equity0.10xInterest CoverageN/A
    Current Ratio3.01xQuick Ratio2.33x
    Trading Statistics
    Beta0.75Avg Volume1.59M
    52-Week High$281.8952-Week Low$179.75

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$233.02
    SMA 20$227.43
    SMA 50$211.88
    SMA 200$227.83
    EMA 10$233.71
    EMA 20$227.42
    EMA 50$217.39
    EMA 200$224.17

    MACD

    Line: 7.94Signal: 7.10Hist: 0.84

    ADX

    ADX: 23.0+DI: 30.5-DI: 13.8

    Aroon & PSAR

    Aroon Up100.0
    Aroon DownN/A
    PSAR$234.04

    Bollinger Bands

    Upper Band$242.93
    Lower Band$211.94
    %B Position1363%(Upper)
    Band Width0.91

    RSI (14-Day)

    Neutral
    69.3

    Momentum Oscillators

    Stoch %K93.6
    Stoch %D93.3
    Williams %R-6.9
    ROC (10d)9.3%
    Momentum20.39
    CCI (20d)131.8
    MFI (14d)79.2

    Volatility Measures

    ATR (14d)$6.59(2.7%)
    StdDev (20d)7.75
    Hist Vol34.5%(Moderate)

    Volume Flow

    VWAP$239.33
    OBV-4.3M
    AD Line-231.4M
    CMF (20d)0.177

    Volume Metrics

    Avg Vol (20d)1.6M
    Vol Ratio1.1x
    VWMA (20d)$226.33

    Pivot Points

    R3$248.64
    R2$244.85
    R1$242.59
    Pivot Point$238.80
    S1$236.54
    S2$232.75
    S3$230.49

    Advanced Oscillators

    TSI30.21
    Ultimate Osc66.2
    KST120.49

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$1.43B$1.42B$1.34B$1.35B$1.29B$1.28B$1.22B$1.22B$1.20B$1.16B$1.10B$1.12B
    Cost of Revenue$540.43M$544.08M$514.76M$527.93M$525.33M$530.81M$507.29M$507.67M$504.20M$515.87M$502.26M$504.67M
    Gross Profit$890.98M$878.72M$820.82M$820.07M$766.41M$751.27M$717.22M$715.53M$692.78M$646.93M$600.06M$617.38M
    Operating Expenses$391.17M$387.06M$374.28M$365.53M$340.14M$334.03M$329.91M$334.31M$318.20M$371.84M$311.06M$342.12M
    R&D$94.27M$90.97M$87.32M$86.44M$83.94M$81.37M$79.52M$80.86M$77.07M$73.88M$75.71M$78.14M
    SG&A$285.65M$278.40M$259.19M$265.13M$245.30M$241.61M$238.98M$242.19M$229.92M$222.16M$222.87M$239.94M
    Operating Income$499.81M$491.66M$446.54M$454.54M$426.27M$417.24M$387.31M$381.22M$374.58M$275.09M$289.00M$275.27M
    Interest Income$14.01M$9.46M$10.28M$1.27M$335,000$1.08M$963,000$-5,052,000$-10,586,000$-13,066,000$-18,852,000$-49,607,000
    Interest Expense$0$0$0$0$8.57M$0$3.81M$23.49M$0$15.64M$16.81M$0
    Income Before Tax$502.31M$496.15M$446.79M$458.05M$417.69M$418.32M$383.50M$357.73M$375.42M$259.45M$272.19M$276.80M
    Income Tax Expense$103.58M$103.56M$98.26M$78.35M$52.65M$73.70M$72.14M$65.50M$74.93M$50.65M$52.77M$47.14M
    Net Income$398.73M$392.59M$348.54M$379.70M$365.04M$344.62M$311.36M$292.24M$300.49M$208.80M$219.42M$229.66M
    EBITDA$557.34M$549.01M$494.18M$525.32M$468.48M$473.92M$437.90M$417.54M$440.65M$325.89M$344.49M$349.17M
    EBIT$488.31M$486.68M$436.51M$451.03M$416.56M$418.02M$384.19M$362.78M$386.01M$272.52M$291.04M$293.97M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RMD

    News

    Frazier Healthcare completes acquisition of MatrixCare from ResMed By Investing.com

    Frazier Healthcare Partners has announced the completion of its acquisition of MatrixCare from ResMed. MatrixCare is a provider of cloud-based electronic health record and revenue cycle management solutions for out-of-hospital care settings, serving over 15,000 providers. Jonathan Lujan has been appointed CEO of MatrixCare following the acquisition, the financial terms of which were not disclosed.

    Investing.com India•9/1/26•
    Neutral

    MatrixCare software serves more than 15,000 providers. Frazier completes the acquisition.

    Frazier Healthcare Partners has completed its acquisition of MatrixCare from ResMed, a leading provider of cloud-based electronic health record and revenue cycle management solutions for out-of-hospital care settings. Concurrent with the acquisition, Jonathan Lujan has been appointed as the new Chief Executive Officer of MatrixCare. The acquisition aims to further invest in product innovation and capabilities for MatrixCare's customers, who include skilled nursing, senior living, home health, and hospice providers.

    Stock Titan•9/1/26•
    Neutral

    ResMed Inc. $RMD Stock Position Raised by Railway Pension Investments Ltd

    Railway Pension Investments Ltd significantly increased its stake in ResMed Inc. (NYSE:RMD) by 406% in Q2, bringing its total holdings to $9.5 million. ResMed reported strong financial results, beating earnings expectations with $2.95 EPS and $1.46 billion in revenue, and increased its quarterly dividend. Despite these positive financial indicators, analysts hold a cautious "Hold" rating on the stock with an average price target of $240.31.

    MarketBeat•9/1/26•
    Somewhat-Bullish

    Quantitative Investment Management LLC Invests $2.21 Million in ResMed Inc. $RMD

    Quantitative Investment Management LLC recently acquired 11,360 shares of ResMed Inc. (NYSE:RMD) valued at approximately $2.21 million during the second quarter. ResMed reported strong quarterly earnings, exceeding estimates with $2.95 EPS and an 8.6% increase in revenue year-over-year. The company also raised its quarterly dividend to $0.66 per share, resulting in an annualized yield of 1.1%, while analysts maintain a consensus "Hold" rating with a target price of $240.31.

    MarketBeat•9/1/26•
    Somewhat-Bullish

    Public Employees Retirement System of Ohio Takes $9.75 Million Position in ResMed Inc. $RMD

    The Public Employees Retirement System of Ohio has acquired a new stake of 50,046 shares in ResMed Inc. (NYSE:RMD) during the second quarter, valued at approximately $9.75 million. This news comes amidst other institutional investors adjusting their positions in the medical equipment provider, while company insiders, including the CEO and a Director, recently sold significant amounts of their stock. Analysts generally rate ResMed as "Hold," with an average target price of $240.31.

    MarketBeat•9/1/26•
    Somewhat-Bullish

    Frequently Asked Questions About RMD

    What is RMD's current dividend yield?
    ResMed Inc (RMD) has a current dividend yield of 1.02%.
    Does RMD pay dividends?
    Yes, ResMed Inc pays dividends with a current yield of 1.02%.
    What is RMD's P/E ratio?
    ResMed Inc has a price-to-earnings (P/E) ratio of 21.50.
    What is RMD's market cap?
    ResMed Inc (RMD) has a market capitalization of $34.63B with a current stock price of $240.13.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In